These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
298 related articles for article (PubMed ID: 16474161)
1. Virus and cell RNAs expressed during Epstein-Barr virus replication. Yuan J; Cahir-McFarland E; Zhao B; Kieff E J Virol; 2006 Mar; 80(5):2548-65. PubMed ID: 16474161 [TBL] [Abstract][Full Text] [Related]
2. Epstein-Barr virus BHRF1 micro- and stable RNAs during latency III and after induction of replication. Xing L; Kieff E J Virol; 2007 Sep; 81(18):9967-75. PubMed ID: 17626073 [TBL] [Abstract][Full Text] [Related]
3. Genome-wide transcription program and expression of the Rta responsive gene of Epstein-Barr virus. Lu CC; Jeng YY; Tsai CH; Liu MY; Yeh SW; Hsu TY; Chen MR Virology; 2006 Feb; 345(2):358-72. PubMed ID: 16298410 [TBL] [Abstract][Full Text] [Related]
4. Detection of Epstein-Barr virus transcripts in chemically or immunologically-activated cells and in a null cell-line (HLN-STL-C) by in situ hybridization with alkaline phosphatase-linked oligonucleotide probes. Hironaka T; Nagasaki M; Morikawa S; Hirai K J Virol Methods; 1993 Oct; 44(2-3):141-54. PubMed ID: 8263111 [TBL] [Abstract][Full Text] [Related]
5. Cellular immediate-early gene expression occurs kinetically upstream of Epstein-Barr virus bzlf1 and brlf1 following cross-linking of the B cell antigen receptor in the Akata Burkitt lymphoma cell line. Ye J; Gradoville L; Miller G J Virol; 2010 Dec; 84(23):12405-18. PubMed ID: 20861250 [TBL] [Abstract][Full Text] [Related]
6. Distinct patterns of viral antigen expression in Epstein-Barr virus and Kaposi's sarcoma-associated herpesvirus coinfected body-cavity-based lymphoma cell lines: potential switches in latent gene expression due to coinfection. Callahan J; Pai S; Cotter M; Robertson ES Virology; 1999 Sep; 262(1):18-30. PubMed ID: 10489337 [TBL] [Abstract][Full Text] [Related]
7. Epstein-Barr virus (EBV) infection in infectious mononucleosis: virus latency, replication and phenotype of EBV-infected cells. Niedobitek G; Agathanggelou A; Herbst H; Whitehead L; Wright DH; Young LS J Pathol; 1997 Jun; 182(2):151-9. PubMed ID: 9274524 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of Epstein-Barr virus-induced growth proliferation by a nuclear antigen EBNA2-TAT peptide. Farrell CJ; Lee JM; Shin EC; Cebrat M; Cole PA; Hayward SD Proc Natl Acad Sci U S A; 2004 Mar; 101(13):4625-30. PubMed ID: 15070768 [TBL] [Abstract][Full Text] [Related]
9. Quantitative profiling of housekeeping and Epstein-Barr virus gene transcription in Burkitt lymphoma cell lines using an oligonucleotide microarray. Bernasconi M; Berger C; Sigrist JA; Bonanomi A; Sobek J; Niggli FK; Nadal D Virol J; 2006 Jun; 3():43. PubMed ID: 16756670 [TBL] [Abstract][Full Text] [Related]
10. Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases. Niller HH; Wolf H; Minarovits J Autoimmunity; 2008 May; 41(4):298-328. PubMed ID: 18432410 [TBL] [Abstract][Full Text] [Related]
11. Three restricted forms of Epstein-Barr virus latency counteracting apoptosis in c-myc-expressing Burkitt lymphoma cells. Kelly GL; Milner AE; Baldwin GS; Bell AI; Rickinson AB Proc Natl Acad Sci U S A; 2006 Oct; 103(40):14935-40. PubMed ID: 17001014 [TBL] [Abstract][Full Text] [Related]
12. De novo protein synthesis is required for lytic cycle reactivation of Epstein-Barr virus, but not Kaposi's sarcoma-associated herpesvirus, in response to histone deacetylase inhibitors and protein kinase C agonists. Ye J; Gradoville L; Daigle D; Miller G J Virol; 2007 Sep; 81(17):9279-91. PubMed ID: 17596302 [TBL] [Abstract][Full Text] [Related]
13. One-step multiplex real-time PCR assay to analyse the latency patterns of Epstein-Barr virus infection. Kubota N; Wada K; Ito Y; Shimoyama Y; Nakamura S; Nishiyama Y; Kimura H J Virol Methods; 2008 Jan; 147(1):26-36. PubMed ID: 17870188 [TBL] [Abstract][Full Text] [Related]
14. Regulation of Epstein-Barr virus latency type by the chromatin boundary factor CTCF. Chau CM; Zhang XY; McMahon SB; Lieberman PM J Virol; 2006 Jun; 80(12):5723-32. PubMed ID: 16731911 [TBL] [Abstract][Full Text] [Related]
15. Epstein-Barr virus replicative gene transcription during de novo infection of human thymocytes: simultaneous early expression of BZLF-1 and its repressor RAZ. Kelleher CA; Paterson RK; Dreyfus DH; Streib JE; Xu JW; Takase K; Jones JF; Gelfand EW Virology; 1995 Apr; 208(2):685-95. PubMed ID: 7747440 [TBL] [Abstract][Full Text] [Related]
16. Immune activation suppresses initiation of lytic Epstein-Barr virus infection. Ladell K; Dorner M; Zauner L; Berger C; Zucol F; Bernasconi M; Niggli FK; Speck RF; Nadal D Cell Microbiol; 2007 Aug; 9(8):2055-69. PubMed ID: 17419714 [TBL] [Abstract][Full Text] [Related]
17. Epstein-Barr Virus-Induced Nodules on Viral Replication Compartments Contain RNA Processing Proteins and a Viral Long Noncoding RNA. Park R; Miller G J Virol; 2018 Oct; 92(20):. PubMed ID: 30068640 [TBL] [Abstract][Full Text] [Related]
18. Nuclear factor-Y and Epstein Barr virus in nasopharyngeal cancer. Chia MC; Leung A; Krushel T; Alajez NM; Lo KW; Busson P; Klamut HJ; Bastianutto C; Liu FF Clin Cancer Res; 2008 Feb; 14(4):984-94. PubMed ID: 18281530 [TBL] [Abstract][Full Text] [Related]